Background. In-center nocturnal hemodialysis (INHD) is associated with favorable left ventricular (LV) remodeling. Although right ventricular (RV) structure and function carry prognostic significance, the impact of dialysis intensification on RV is unknown. Our objectives were to evaluate changes in RV mass index (MI), end-diastolic volume index (EDVI), end-systolic volume index (ESVI) and ejection fraction (EF) after conversion to INHD and their relationship with LV remodeling. Methods. Of 67 conventional hemodialysis (CHD, 4 h/session, three times/week) patients, 30 continued on CHD and 37 converted to INHD (7-8 h/session, three times/week). Cardiac magnetic resonance imaging was performed at baseline and 1 year using a standardized protocol; an experienced and blinded reader performed RV measurements. Results. At 1 year there were significant reductions in RVMI {À2.1 g/m 2 [95% confidence interval (CI) À3.8 to À 0.4], P ¼ 0.017}, RVEDVI [À9.5 mL/m 2 (95% CI À 16.3 to À 2.6), P ¼ 0.008] and RVESVI [À6.2 mL/m 2 (95% CI À 10.9 to À 1.6), P ¼ 0.011] in the INHD group; no significant changes were observed in the CHD group. Between-group comparisons showed significantly greater reduction of RVESVI [À7.9 mL/m
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Background. In-center nocturnal hemodialysis (INHD) is associated with favorable left ventricular (LV) remodeling. Although right ventricular (RV) structure and function carry prognostic significance, the impact of dialysis intensification on RV is unknown. Our objectives were to evaluate changes in RV mass index (MI), end-diastolic volume index (EDVI), end-systolic volume index (ESVI) and ejection fraction (EF) after conversion to INHD and their relationship with LV remodeling. Methods. Of 67 conventional hemodialysis (CHD, 4 h/session, three times/week) patients, 30 continued on CHD and 37 converted to INHD (7-8 h/session, three times/week). Cardiac magnetic resonance imaging was performed at baseline and 1 year using a standardized protocol; an experienced and blinded reader performed RV measurements. Results. At 1 year there were significant reductions in RVMI {À2.1 g/m 2 [95% confidence interval (CI) À3.8 to À 0.4], P ¼ 0.017}, RVEDVI [À9.5 mL/m 2 (95% CI À 16.3 to À 2.6), P ¼ 0.008] and RVESVI [À6.2 mL/m 2 (95% CI À 10.9 to À 1.6), P ¼ 0.011] in the INHD group; no significant changes were observed in the CHD group. Between-group comparisons showed significantly greater reduction of RVESVI [À7.9 mL/m 2 (95% CI À 14.9 to À 0.9), P ¼ 0.03] in the INHD group, a nonsignificant trend toward greater reduction in RVEDVI and no significant difference in RVMI and RVEF changes. There was significant correlation between LV and RV in terms of changes in mass index (MI) (r ¼ 0.46), EDVI (r ¼ 0.73), ESVI (r ¼ 0.7) and EF (r ¼ 0.38) over 1 year (all P < 0.01). Conclusions. Conversion to INHD was associated with a significant reduction of RVESVI. Temporal changes in RV mass, volume and function paralleled those of LV. Our findings support the need for larger, longer-term studies to confirm favorable RV remodeling and determine its impact on clinical outcomes.
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Conventional hemodialysis (CHD) is the dominant form of renal replacement therapy for end-stage renal disease (ESRD) and is routinely administered in 4-h sessions, three times per week [1] . Despite advances in medical care, patients on chronic dialysis continue to have unacceptable cardiovascular mortality rates as high as 15-20% annually [2] . There has been growing interest in dialysis intensification to improve cardiovascular outcomes. Left ventricular (LV) hypertrophy is common in the dialysis population [3] and the change in left ventricular mass (LVM) has been used as a surrogate endpoint in major randomized controlled trials of dialysis intensification [4, 5] In-center nocturnal hemodialysis (INHD) administered over 7-8 h sessions, three times per week is associated with improved mineral metabolism and quality of life [6] . Significant LVM regression has been demonstrated in patients who converted to INHD compared with those who remained on CHD [7] .
Hypertension, inflammation, anemia and the toxic milieu of ESRD, which have been implicated in LV remodeling and cardiomyopathy, may injure the right ventricle (RV) as well [8] . Dialysis recipients are also susceptible to numerous stresses that target the RV. RV dysfunction may be a direct consequence of pulmonary hypertension, which is common in dialysis recipients. The physiology and clinical importance of the RV have been described by Dell'Italia [8] . Pathophysiologic mechanisms for pulmonary hypertension include arteriovenous fistula (AVF)-induced increased cardiac output, endothelial dysfunction, dysregulation of vascular tone due to an imbalance in vasoactive substances (nitric oxide) and local and systemic inflammation. Despite this, there are only limited data on RV structure and function in the dialysis population. A few studies have utilized echocardiography, which is suboptimal for RV assessment [9] [10] [11] [12] . Cardiac magnetic resonance (CMR) imaging is considered the reference standard for RV assessment due to excellent delineation of the endocardial borders, relatively high spatial and temporal resolution and true volumetric measurements without any geometric assumptions [13] . Despite the known prognostic significance of RV dysfunction in various disease states [14] [15] [16] [17] , there are no published studies that have used CMR for RV assessment in the dialysis population. Furthermore, the impact of INHD, or any form of intensified dialysis, on RV structure and function has not been studied.
Our primary objective was to evaluate changes in the RV mass index (RVMI), RV end-diastolic volume index (RVEDVI), RV end-systolic volume index (RVESVI) and RV ejection fraction (RVEF) after conversion to INHD. We also examined the relationship between RV remodeling in relation to concurrent structural changes in the LV.
M A T E R I A L S A N D M E T H O D S

Participants
In a two-center prospective cohort study of patients with ESRD, we previously demonstrated significant LVM regression in patients who converted to INHD compared with those who remained on CHD [7] . In the present study we examine the changes in RV volume and EF in this cohort of patients.
Details of the study design have been previously published [7] . Briefly, this prospective observational study was conducted with 67 patients who had been on CHD for at least 90 days at two university-affiliated tertiary care centers in Canada, St Michael's Hospital (Toronto) and St Paul's Hospital (Vancouver). CHD was administered for 3-4 h per session and INHD for 7-8 h per session, both three times a week. The decision to convert to INHD was jointly made by the treating nephrologist and the patient. The exclusion criteria were the same for both the INHD and CHD groups and included serious comorbidities with life expectancy <1 year, planned renal transplant from a live donor in the coming year, contraindications to CMR and confirmed pregnancy. Thirty-seven patients converted to INHD and 30 individuals who chose to remain on CHD were recruited as the control group. All patients in the CHD arm continued on their previous dialysis prescription. All fundamental aspects of hemodialysis care conformed to prevailing guidelines during the study period and did not differ between the two groups. Approval of the Research Ethics Boards of each site and written consent from all participants were sought.
Follow-up
Planned follow-up for all patients was 52 weeks. This was preceded by a 12-week baseline period during which all patients were on CHD. During this time, baseline CMR scans were performed. We collected clinical and biochemical data including blood pressure, intradialytic weight gain, concentration of serum phosphate, high-sensitivity troponin I, N-terminal B-type natriuretic peptide (NT-BNP) and fibroblast growth factor 23 . At the conclusion of the 52-week follow-up, a 12-week end-of-study (EOS) period commenced during which the subjects continued on the same dialysis schedule and the same array of investigations was conducted and similar data were collected.
CMR acquisition and post-processing
All CMR examinations (except for one patient who could not fit into the 1.5 T scanner, thus a 3 T scanner was used) were performed using a 1.5 T MRI scanner with a phased-array cardiac coil, retrospective vector-cardiographic gating and a standardized protocol [18] . All CMR post-processing was performed using cvi42 software (Circle Cardiovascular Imaging, Calgary, Alberta, Canada). LV measurements were performed by an experienced blinded cardiologist (A.T.Y.) [7] . RV measurements were performed offline separately by a cardiac radiologist (G.R.K.) who was blinded to the treatment group, order of exam and LV and other clinical data. RV endocardial and epicardial contours were manually drawn using standard techniques on the short-axis SSFP images, which did not include trabeculation or papillary muscle mass for volumetric and mass calculation [19] . RV hypertrophy (RVH) was defined as RVMI >29 g/m 2 in men and >28 g/m 2 in women [20] . To ensure accuracy and reliability, 10 months after the initial image analysis, 20 cases were randomly selected and the blinded cardiac radiologist repeated the post-processing without knowledge of the previous calculations or order of the study. Intraobserver agreement was excellent, with intraclass correlation coefficients of 0.99 [95% confidence interval (CI) 0.98-1] for RVEDVI, 0.98 (95% CI 0.95-1) for RVESVI and 0.96 (95% CI 0.89-0.98) for RVMI.
Statistical analysis
Means (6 standard deviation) or medians (interquartile range) were used to describe continuous variables. Intergroup comparisons were made using the t-test or Mann-Whitney U-test, as appropriate. Within each group, baseline and EOS comparisons were made by the paired t-test. For the primary analysis, we compared the differences in 1-year changes (EOS minus baseline) between the two groups with respect to RV parameters and reported 95% CIs. Multivariable linear regression was performed to adjust for baseline differences in the INHD and CHD recipients, where the change in the RV parameter (mass, volume or EF) was the dependent variable and dialysis modality (INHD versus CHD), age, number of months on dialysis, diabetes mellitus and vascular access type were the independent variables. Pearson's correlation was used to examine the relationships between RV and LV parameters and Spearman's (nonparametric) correlation was used for relationships with biomarkers. A two-sided P-value <0.05 was considered statistically significant. All analyses were conducted with SPSS version 22 (IBM, Armonk, NY, USA).
R E S U L T S
Thirty-seven patients converted to INHD from CHD while 30 patients eligible for INHD remained on CHD and served as controls. Patients who converted to INHD were older, more likely to have diabetes, less likely to have glomerulonephritis and had a shorter dialysis history compared with the control group. Cardiovascular and selected laboratory parameters at baseline are shown in Table 1 . At baseline, a total of only seven patients had RVH. At 1 year, 10 patients did not undergo follow-up CMR due to receipt of a renal transplant (n ¼ 2), serious morbidity or death (n ¼ 8); 1 patient had an incomplete follow-up CMR and was excluded from this analysis.
RV mass, volumes and EF
In the control group, baseline to EOS comparisons using the paired t-test did not show significant changes over 1 Despite the larger reduction in RVMI in the INHD group, the difference in 1-year changes between the two groups was not significant [À1.9 g/m 2 (95% CI À4.6-0.8), P ¼ 0.16] (Figure 1) . Similarly, the differences in 1-year changes in RVEDVI [À9.4 mL/m 2 (95% CI À20.3-1.4), P ¼ 0.09] and RVEF [3.6% (95% CI À1.9-9.1), P ¼ 0.19] were also not significant (Figures 2 and 3) . However, the difference in 1-year change in RVESVI was significant [À7.9 mL/m 2 (95% CI À14.9 to À0.9), P ¼ 0.03] (Figure 4) . The results were similar in multivariable regression analysis ( Table 2) . 
Relationship between RV and LV remodeling
The changes in RV parameters paralleled those in LV, with positive and moderate to strong correlations (Table 3) .
Vascular access and biomarkers
Of the 67 patients at baseline, 39 patients had an AVF/graft and 28 patients had a central venous catheter (CVC) for vascular access. Of the 28 patients with a CVC, 5 converted to an AVF/ graft, 1 patient had a catheter change and the remainder continued with a CVC; 1 of 39 patients with an AVF/graft switched to a CVC due to graft failure. There was no association between access type and RV parameters at baseline or over 1 year.
Among biomarkers, significant correlation existed only between the change in RVESVI and NT-BNP (r ¼ 0.3, P ¼ 0.04) ( Table 4 ). There was no significant correlation between NT-BNP, troponin I and RV mass and volume indices or EF. RV parameters also did not show any significant correlation with interdialytic weight gain and systolic blood pressure (Table 4) .
D I S C U S S I O N
We found that conversion to INHD was associated with a significant reduction in RV mass and volume indices at 1 year. Compared with the control group, the INHD group showed significantly greater reduction in the RVESVI, while the reductions in the RVMI, RVEDVI and increase in RVEF were not significant. The temporal changes in RV volume and function paralleled those observed in the LV.
The pathophysiology of cardiac remodeling in dialysis patients is complex and likely mediated by myriad mechanical and biochemical factors. These include persistent volume overload, fluctuating volume status, coexisting hypertension, accumulation of uremic toxins, inflammation, anemia and endocrine axis derangements [21] . We postulate that these same factors leading to adverse LV remodeling would also contribute to RV remodeling. Furthermore, AVFs/grafts in chronic dialysis patients increase the preload on the right heart and might impact its performance [22] . There is a high prevalence In-center nocturnal hemodialysis and right ventricular remodeling of pulmonary hypertension in dialysis patients, ranging between 17% and 49.5%, depending on the mode of dialysis and other cardiovascular comorbidities [23] . Impairment of pulmonary circulation along with chronic volume overload and high levels of fibrosis promoting cytokines and growth factors, namely platelet-derived growth factor, FGF and transforming growth factor-b, likely contribute to pulmonary hypertension [21] . Endothelial dysfunction, lower activity of nitric oxide synthase and increased levels of serum endothelin promote extensive growth of endothelial cells, leading to complete obliteration of pulmonary vessels [22] . Vasoconstriction and vascular sclerosis triggered by microbubbles escaping from the dialysis circuit have also been implicated [24] . Furthermore, hemostatic mechanisms have been described linking ESRD and dialysis with increased risk of pulmonary venous thromboembolism [25] , which could impair right heart function.
Multiple mechanisms have been proposed for the cardiovascular benefits of INHD. Due to improved blood pressure control, patients who convert to INHD require fewer antihypertensive medications [7, 26, 27] . LV hypertrophy is strongly associated with hypertension and thus improved blood pressure control likely contributes to LV mass regression in INHD patients [28] . Extracellular volume expansion is the main pathophysiological determinant of hypertension in dialysis patients [29] . INHD has shown improved control of extracellular volume excess by reducing the time-averaged fluid load [30] . INHD may also more closely approximate the capacity of a native or transplanted kidney to regulate extracellular volume and solute composition [30] [31] [32] . Improved mineral metabolism with lower serum phosphate and calcium-phosphate products has been demonstrated in several studies [6, 26, 27, 33] . Studies have also suggested that nocturnal hemodialysis is associated with improved vascular risk in patients with ESRD by playing a role in restoration of abnormal smooth muscle cell biology [34] . Studies suggest that these mechanisms may promote favorable RV remodeling as well [35] . Our findings suggest that these mechanisms may promote favorable RV remodeling as well. The INHD group demonstrated improvements in the RVEDVI and RVEF, even though these differences were not statistically significant compared with the control group. Interestingly, conversion to INHD was associated with a significant reduction in the RVESVI. We found that the temporal changes in RV volume and function paralleled those of the LV and were in a similar direction with moderate to strong association. This further supports the notion that the beneficial effects of INHD on the LV also impact the RV.
The significance of reduction of the RVESVI in the hemodialysis population remains to be studied. RV dysfunction is prognostically important in various disease states, such as coronary artery disease, where depiction of RV wall motion abnormalities on stress echocardiography has independent and incremental prognostic value even over LV wall motion abnormalities [14] . In tetralogy of Fallot patients, the RVESVI has been identified as a more sensitive marker of reverse remodeling after pulmonary valve replacement [15] . In nonischemic dilated cardiomyopathy, RV systolic dysfunction has been shown to be a powerful independent predictor of cardiac transplant-free survival and adverse heart failure outcomes [16] . Furthermore, reevaluation of the RVEF during follow-up conferred additive long-term prognostic value [17] . Therefore, 
À7.7 (1.2-13.6) À7.9 (À14.9 to À 0.9) P ¼ 0. our findings raise the interesting hypothesis that favorable RV structural and functional changes might also lead to improved clinical outcomes in the setting of ESRD. Despite evidence linking RV dysfunction with chronic dialysis and demonstration of RV function as an independent prognosticator in other conditions, there exists a significant knowledge gap. LV mass is a well-established, powerful, independent prognosticator that has been used in multiple randomized controlled trials evaluating newer dialysis modalities [3] [4] [5] . While CMR has shown favorable LV changes in INHD patients, CMR assessment of the RV has not been systematically performed in patients on conventional or intensified hemodialysis. Only a few studies have attempted to assess the RV in hemodialysis patients using echocardiography [9] [10] [11] . These were cross-sectional studies with a small number of patients that only assessed acute hemodynamic effects of dialysis using echocardiography with no long-term follow-up. There are no published studies that have assessed RV mass, volume and systolic function using the reference standard CMR in a longitudinal fashion, in INHD or in any form of intensified dialysis. Echocardiographic assessment of the RV is known to be inaccurate due to its complex geometry, predominant contribution of longitudinal motion to systolic function, difficult visualization due to anterior location and near-field artifact [36, 37] . Furthermore, based on the anatomy, structure and function, the RV is divided into the inflow and outflow tracts and therefore is not amenable to simple geometric assumptions [38, 39] . The RV is thin-walled (2-4 mm) with a muscle mass approximately one-sixth that of the LV. Therefore, even with the excellent spatial resolution ($1.5-2 mm) and signal:noise ratio in CMR, we may not be able to detect small changes in RV mass, in contrast to relatively small changes in LV mass. Nevertheless, CMR remains the best available technique for the assessment of RV structure and function that does not require geometric assumptions. Our study therefore provides novel insights into the pathophysiology of RV remodeling in INHD patients. It also highlights the need for larger and longer-term follow-up studies to detect significant RV changes.
CVC use was relatively high in our patients, comprising 41.8% of the overall cohort and 56.8% of the INHD patients. There are several reasons for this phenomenon. A greater proportion of INHD patients had diabetes and tend to have vasculature that is less amenable to creation of a permanent vascular access. The INHD patients received dialysis for a shorter period of time compared with the control group at recruitment, and therefore they were more likely to remain on hemodialysis with a CVC. Only a minority of patients switched vascular access during the follow-up period. Studies using echocardiography have shown that RV abnormalities and hypertrophy are more frequent in patients on hemodialysis compared with peritoneal dialysis, particularly those with an AVF as opposed to a CVC, likely related to development of pulmonary hypertension [40] [41] [42] . In contrast to these studies, we observed no significant difference in RV structure and function at baseline or changes over 1 year with respect to the vascular access. The small number of participants in our study might have limited the power to detect differences.
Our study showed a borderline significant correlation between change in the RVESVI and NT-proBNP. While this correlation may represent a chance finding, an elevated BNP level might reflect increased filling pressure in both ventricles. However, we did not find any significant relationship between RV measurements and interdialytic weight gain as a measure of volume overload and systolic blood pressure. It is possible that the relative importance of these factors is different in LV and RV remodeling. We also did not observe any relationship between biomarkers of cardiomyocyte injury and myocardial fibrosis (high-sensitivity troponin I and FGF23, respectively) and RV remodeling. Further studies to elucidate mechanisms of LV and RV remodeling in ESRD are needed.
To our knowledge, this is the first prospective longitudinal study that performed rigorous RV assessment in the intensified dialysis population using the reference imaging standard CMR. All RV measurements were independently performed by a single experienced reader who was blinded not only to the order of examination and other clinical data, but also the LV measurements. However, our study had several limitations, including a small sample size, which might have limited our power to demonstrate subtle changes in RV structure and function. Despite our efforts to minimize bias due to observed baseline differences, there probably existed unmeasured confounders in this nonrandomized study. The small sample size of our study also likely limited the power to demonstrate any relationship between vascular access and RV remodeling. Larger and longer-term prospective studies using CMR are required to elucidate this in the future. Finally, as we did not assess RV remodeling beyond 1 year, our study might not detect more gradual remodeling of RV.
In conclusion, compared with continuation of CHD, conversion to INHD was associated with a significant reduction of RVESVI, along with a trend toward improvements in RVMI, the RVEDVI and RVEF. The parallel changes in LV and RV structure and function suggest that similar salutary mechanisms might mediate favorable remodeling in both ventricles. Our findings support future larger prospective studies with longer-term followup to elucidate the impact of dialysis intensification on the RV. 
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